Fierce Pharma
NOVEMBER 23, 2022
Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line. zbecker. Wed, 11/23/2022 - 10:10
PharmaVoice
NOVEMBER 22, 2022
How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare Success
NOVEMBER 21, 2022
Just like your brick-and-mortar business has to be ADA compliant, your healthcare website must also be accessible to people with disabilities. The problem? The ADA doesn’t offer clear regulations for a compliant website. The bigger problem? ADA accessibility lawsuits are on the rise.
PharmExec
NOVEMBER 22, 2022
The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.
.png)
Fierce Pharma
NOVEMBER 23, 2022
On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane. kdunleavy. Wed, 11/23/2022 - 09:35
PharmaVoice
NOVEMBER 22, 2022
Evelina Vågesjö, co-founder and CEO of the immunotherapy company Ilya Pharma, is working on a new modality to speed wound healing
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmExec
NOVEMBER 24, 2022
In episode 122, Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits into the future of pharmaceutical marketing.
Fierce Pharma
NOVEMBER 23, 2022
Senator aims to cut biosimilar 'red tape' with proposal to eliminate interchangeable status. kdunleavy. Wed, 11/23/2022 - 07:18
PharmaVoice
NOVEMBER 21, 2022
The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer
Eversana Intouch
NOVEMBER 21, 2022
Download the White Paper. Big concepts. Big platforms. Big words. Big decisions. That’s where we all want to play. It’s easy to toss big words around, though: to be provocative, to hype, to make unsupported claims. It’s far more difficult to be precise, accurate, meaningful. To have impact.
Penrod
NOVEMBER 23, 2022
The post Customer Data Platforms: A Healthcare Perspective appeared first on Penrod
Fierce Pharma
NOVEMBER 23, 2022
J&J's nasal spray Spravato bests former AZ drug Seroquel XR in treatment-resistant depression trial. fkansteiner. Wed, 11/23/2022 - 09:26
PharmaVoice
NOVEMBER 21, 2022
Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound
PharmExec
NOVEMBER 21, 2022
Webinar Date/Time: Mon, Dec 5, 2022 2:00 PM EST. us
Pharma Pathway
NOVEMBER 25, 2022
Zydus Lifesciences Limited-Walk-In Interviews for B.Pharm, M.Pharm/ Diploma/ ITI in Production OSD On 27th Nov’ 2022. Job Description. We are recruiting for B.Pharm, M.Pharm/ Diploma/ ITI in Production OSD for Our Formulation Manufacturing Plant at Moraiya, Ahmedabad.
Fierce Pharma
NOVEMBER 23, 2022
Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits. fkansteiner. Wed, 11/23/2022 - 08:05
Pharmaceutical Technology
NOVEMBER 25, 2022
Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’.
PharmExec
NOVEMBER 21, 2022
Webinar Date/Time: Wed, Dec 7, 2022 2:00 PM EST. us
PM360
NOVEMBER 21, 2022
If you aren’t yet familiar with the term “digital front door,” you soon will be. Not only because we will soon define it for you, but because you will be hearing about it a lot over the next few years.
Fierce Pharma
NOVEMBER 22, 2022
Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck. fkansteiner. Tue, 11/22/2022 - 10:07
Pharma Pathway
NOVEMBER 25, 2022
Nectar Lifesciences Ltd- Walk-In Interviews for Production / QC/ QA/ Engineering/ SRP On 27th Nov’ 2022. Job Description. Walk-In Interviews for Production / QC/ QA/ Engineering/ SRP On 27th Nov’ 2022 Candidates @ Nectar Lifesciences Ltd.
PharmaTech
NOVEMBER 21, 2022
Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.
Integrity Solutions
NOVEMBER 22, 2022
With employee turnover one of the most serious internal threats credit unions and banks face today, many forward-thinking financial institutions are taking a hard look at their organizations culture and opportunities to change.
Fierce Pharma
NOVEMBER 21, 2022
ASH: AbbVie, J&J's Imbruvica under serious threat as BeiGene's Brukinsa delivers head-to-head trial win. Mon, 11/21/2022 - 16:29
Pharma Pathway
NOVEMBER 19, 2022
Raichem Medicare Pvt. Ltd-Walk-In Interview for Production / Shift Incharge On 21st Nov’ 2022. Job Description. Walk-In Interview for Production / Shift Incharge On 21st Nov’ 2022 @ Raichem Medicare Pvt. Ltd -Hyderabad. Departments: Production / Shift Incharge. Division: API.
Medgadget
NOVEMBER 24, 2022
Researchers at Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have developed a DNA toolbox that allows researchers to explore binding interactions between ligands and their respective receptors based on receptor density and arrangement.
Legacy MEDSearch
NOVEMBER 23, 2022
The holiday season always brings a time of family, friends, good food, and also reflection on the year. This year as we are in the season of giving thanks, we asked our team what everyone was thankful for this holiday season. Here is what they had to say!
Fierce Pharma
NOVEMBER 21, 2022
Pfizer's Paxlovid access brought into question as WTO set to discuss patent waiver—again. Mon, 11/21/2022 - 11:21
Pharma Pathway
NOVEMBER 19, 2022
Lincoln Pharmaceuticals Ltd-Walk-In Interview for Production/ Packing/ ADL/ Packing/ QA/ QC/ F&D/ Engineering On 27th Nov’ 2022. Job Description.
MedCity News
NOVEMBER 22, 2022
Based on some independent research that my company commissioned with more than 200 companies, we came to several conclusions that are highlighted in the article. Broadly, however, it signals the false sense of (cyber)security that many companies are currently harboring.
Legacy MEDSearch
NOVEMBER 22, 2022
New View Surgical, Inc., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced the closure of a $12.1M Series B-1 equity financing round to fund the commercialization of its VisionPort System.
Fierce Pharma
NOVEMBER 22, 2022
Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says. kdunleavy. Tue, 11/22/2022 - 11:13
Pharma Pathway
NOVEMBER 19, 2022
Hetero Limited-Walk-In Interview for Freshers -Production/ QA/ QC/ Maintenance On 22nd Nov’ 2022. Job Description. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.
European Pharmaceutical Review
NOVEMBER 23, 2022
The US Food and Drug Administration (FDA) has approved Hemgenix (etranacogene dezaparvovec), the first gene therapy for adults with Haemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening haemorrhage, or have repeated, serious spontaneous bleeding episodes.
Expert insights. Personalized for you.
247 
Let's personalize your content